Cardiovascular phenotype of the Dmdmdx rat – a suitable animal model for Duchenne muscular dystrophy

Left ventricular dysfunction in Duchenne muscular dystrophy

(2020) Katherine A. James et al.   CARDIOLOGY IN THE YOUNG

Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy

(2020) Nalinda B. Wasala et al.   MOLECULAR THERAPY

Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice

(2020) David Santer et al.   ESC Heart Failure

Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction

(2019) Patrick M. Pilz et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment

(2019) Laure-Hélène Ouisse et al.   Frontiers in Immunology

Tracking progress: an update on animal models for Duchenne muscular dystrophy

(2018) Dominic J. Wells   Disease Models & Mechanisms

Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis

(2018) Bruno K. Podesser et al.   JOURNAL OF HYPERTENSION

Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse

(2018) Selma Osmanagic-Myers et al.   JOURNAL OF CLINICAL INVESTIGATION

Central Arterial Function Measured by Non-invasive Pulse Wave Analysis is Abnormal in Patients with Duchenne Muscular Dystrophy

(2017) Thomas D. Ryan et al.   PEDIATRIC CARDIOLOGY

ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies

(2017) Vincenzo Russo et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice

(2017) Antanina Voit et al.   Nature Communications

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy

(2017) Marly Conceição Silva et al.   JAMA Cardiology

Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy

(2016) Tetsuro Yokokawa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy

(2015) J. W. McGreevy et al.   Disease Models & Mechanisms

Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension

(2015) Mária Szekeres et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Skeletal Muscle Fibrosis in the mdx/utrn+/- Mouse Validates Its Suitability as a Murine Model of Duchenne Muscular Dystrophy

(2015) Kelly M. Gutpell et al.   PLoS One

NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy

(2014) Daniel R. Gonzalez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy

(2014) Ying Li et al.   CARDIOVASCULAR RESEARCH

PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy

(2014) M. D. Nelson et al.   NEUROLOGY

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human

(2014) Miklós Fagyas et al.   PLoS One

Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy

(2014) Thibaut Larcher et al.   PLoS One

Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery

(2013) Xuan Guan et al.   Stem Cell Research

Vascular-targeted therapies for Duchenne muscular dystrophy

(2013) James P Ennen et al.   Skeletal Muscle

Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies

(2012) Natalia Shirokova et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases

(2012) Dawn A. Delfín et al.   NEUROMUSCULAR DISORDERS

Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy

(2011) Irena Niebroj-Dobosz et al.   CLINICA CHIMICA ACTA

Cardiomyopathy of duchenne muscular dystrophy: Current understanding and future directions

(2011) Christopher F. Spurney   MUSCLE & NERVE

Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart

(2011) Xaver Koenig et al.   PLoS One

Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension

(2010) Dalia Urboniene et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Cardiac Findings in Congenital Muscular Dystrophies

(2010) J. Finsterer et al.   PEDIATRICS

Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy

(2010) J. Fauconnier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart

(2010) J. Kuroda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction-Induced Ventricular Arrhythmia and Mortality in Mice

(2009) Dylan E. Burger et al.   CIRCULATION

Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy

(2009) Rita Wen Kaspar et al.   Journal of the American Academy of Nurse Practitioners